Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 13Obesity 6Weight Loss 5Overweight 3Menstruation Disturbances 2Intermittent Fasting 2Insulin Resistance 2Tumor Surgery 1Sarcopenia 1Postoperative Complications 1Obesity, Abdominal 1Muscle Weakness 1Motor Activity 1Moderately Overweight Individuals 1Metabolic Syndrome 1Metabolic Diseases 1Infertility 1Glucocorticoid Receptor Deficiency 1Fasting 1Esophageal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Breast Cancer Female 1Body Weight 1

Interventions

Exercise 3Metformin 2Megestrol Acetate 2Yoga 1Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1Sitagliptin Phosphate 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Professional Autonomy 1Prebiotics 1Nutrition Assessment 1Motivational Interviewing 1Mirtazapine 1Magnetic Resonance Spectroscopy 1Hematologic Tests 1Doxorubicin 1Dietary Supplements 1Diet Therapy 1Diet 1Cyclophosphamide 1Cisplatin 1Caseins 1Caloric Restriction 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Body Weight × Caloric Restriction × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡